Minnesota Lung Center
Minneapolis, Minnesota 55435
0 studies enrolling now · 15 studies all time
What they study most
COPD, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Idiopathic Hypersomnia, Idiopathic Pulmonary Fibrosis, Lung Diseases, Obstructive, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive
Studies at this site
- POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy) — Stopped early
- Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment — Completed
- Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis — Status unconfirmed
- A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
- Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis — Completed
- Portable Oxygen Concentrator Improvements to Physical Activity, Oxygen Usage, and Quality of Life in Chronic Obstructive Pulmonary Disease Patients Using Long-term Oxygen Therapy (POC-STEP) — Stopped early
- A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension — Completed
- Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment — Completed
- Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4) — Completed
- A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD — Completed
- A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease — Completed
- Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF — Completed
- To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD — Completed
- Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
- 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed